Dimerix Company Profile

12:01 EDT 25th June 2018 | BioPortfolio

Dimerix is a privately owned drug discovery company which focuses on fully validated drug targets and leverages existing knowledge on drug-like molecules. As a consequence, Dimerix leapfrogs the initial, low-value drug discovery steps. Using innovative technologies, these existing drugs or drug-like compounds are modified in a rationale way to enhance their properties and achieve higher efficacy. The time to enter clinical trials is expected to take 2-3 years which is significantly shorter than the industry’s average of 5-8 years


WAIMR, B-Block, Hospital Ave
Western Australia
WA 6009



News Articles [9 Associated News Articles listed on BioPortfolio]

Dimerix: Advancing new drug therapies through the clinic for unmet medical needs

Dimerix Limited is a clinical stage, biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB). The Company is focused on developing new therapeutics discovered using its proprie...

BRIEF—Dimerix appoints chief medical officer

Melbourne’s Dimerix has appointed David Packham as chief medical officer. Mr Packham will head development…

Dimerix appoints Chief Medical Officer

Appointments: Changes at Menarini, Emergent BioSolutions, Novo Nordisk, Sienna Biopharmaceuticals, The Medicines Company and DImerix

This week's appointment announcements include a new chair at Menarini, a new president and COO, and a new CFO at...    

Dimerix Raises a Further AU $4.5m Through Oversubscribed Placement

Dimerix raises a further AU $4.5 million via a significantly oversubscribed Placement. The Capital Raising was expanded to meet very strong demand from existing and new institutional, sophist...

Recorded interview with CEO and rights issue reminder

MELBOURNE, Australia, 15 January 2018: Dimerix Limited (ASX: DXB), is pleased to provide shareholders with access to a recorded interview where CEO, Kathy Harrison discusses the recent dose optimisa...

Kidney disease trial shows two drugs are better than one

Kidney Health Australia states that around one in 10 Australians aged 18 years and over has indicators of chronic kidney disease (CKD), such as reduced kidney function and proteinuria — the presence...

Dimerix Limited: CMO Appointment and Clinical Trials Update

Chronic Kidney Disease expert, Associate Professor David Packham appointed to newly created role of Chief Medical Officer to lead development of Dimerix’s lead therapeutic program, DMX-200 ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


Dimerix is a privately owned drug discovery company which focuses on fully validated drug targets and leverages existing knowledge on drug-like molecules. As a consequence, Dimerix leapfrogs the initi...

Dimerix Bioscience Pty Ltd

Dimerix is a Perth-based drug discovery company focused on developing pharmaceutical products targeting heteromers or complexes of GPCRs. Approximately 40% of all currently market...

More Information about "Dimerix" on BioPortfolio

We have published hundreds of Dimerix news stories on BioPortfolio along with dozens of Dimerix Clinical Trials and PubMed Articles about Dimerix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dimerix Companies in our database. You can also find out about relevant Dimerix Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record